MANKIND — Mankind Pharma Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual balance sheet for Mankind Pharma, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	2021 March 31st	2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IAS	IAS	IAS	IAS	IAS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	20,172	12,943	15,216	33,865	24,851
Net Total Accounts Receivable
Net Total Receivables	5,669	11,106	12,184	14,497	22,247
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	39,066	44,068	43,279	65,682	69,883
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	19,917	23,896	30,170	31,387	32,140
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	63,726	91,477	97,154	119,633	277,595
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	13,534	26,235	18,631	21,197	56,636
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	16,506	29,925	22,802	26,002	134,271
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	47,220	61,552	74,352	93,631	143,324
Total Liabilities & Shareholders' Equity	63,726	91,477	97,154	119,633	277,595
Total Common Shares Outstanding